27631520|t|Novel High-grade Endometrial Stromal Sarcoma: A Morphologic Mimicker of Myxoid Leiomyosarcoma
27631520|a|Endometrial stromal sarcomas (ESS) are often underpinned by recurrent chromosomal translocations resulting in the fusion of genes involved in epigenetic regulation. To date, only YWHAE-NUTM2 rearrangements are associated with distinctive high-grade morphology and aggressive clinical behavior. We identified 3 ESS morphologically mimicking myxoid leiomyosarcoma of the uterus and sought to describe their unique histopathologic features and identify genetic alterations using next-generation sequencing. All cases displayed predominantly spindled cells associated with abundant myxoid stroma and brisk mitotic activity. Tumors involved the endometrium and demonstrated tongue-like myometrial infiltration. All 3 were associated with an aggressive clinical course, including multisite bony metastases in 1 patient, progressive peritoneal disease after chemotherapy in another, and metastases to the lung and skin in the last patient. All 3 ESS were found to harbor ZC3H7B - BCOR gene fusions by targeted sequencing and fluorescence in situ hybridization. On the basis of the review of these cases, we find that ESS with ZC3H7B - BCOR fusion constitutes a novel type of high-grade ESS and shares significant morphologic overlap with myxoid leiomyosarcoma.
27631520	6	44	High-grade Endometrial Stromal Sarcoma	T038	UMLS:C2239246
27631520	48	68	Morphologic Mimicker	T033	UMLS:C0243095
27631520	72	93	Myxoid Leiomyosarcoma	T038	UMLS:C0205816
27631520	94	122	Endometrial stromal sarcomas	T038	UMLS:C0206630
27631520	124	127	ESS	T038	UMLS:C0206630
27631520	164	190	chromosomal translocations	T038	UMLS:C0040715
27631520	208	223	fusion of genes	T062	UMLS:C0178648
27631520	236	257	epigenetic regulation	T038	UMLS:C0007613
27631520	273	284	YWHAE-NUTM2	T017	UMLS:C4287955
27631520	285	299	rearrangements	T038	UMLS:C0017287
27631520	358	386	aggressive clinical behavior	T033	UMLS:C0243095
27631520	404	407	ESS	T038	UMLS:C0206630
27631520	408	433	morphologically mimicking	T033	UMLS:C0243095
27631520	434	455	myxoid leiomyosarcoma	T038	UMLS:C0205816
27631520	463	469	uterus	T017	UMLS:C0042149
27631520	544	563	genetic alterations	T038	UMLS:C0026882
27631520	570	596	next-generation sequencing	T062	UMLS:C2936625
27631520	632	646	spindled cells	T017	UMLS:C0007634
27631520	679	685	stroma	T017	UMLS:C0927195
27631520	696	712	mitotic activity	T033	UMLS:C1334779
27631520	714	720	Tumors	T038	UMLS:C0027651
27631520	734	745	endometrium	T017	UMLS:C0014180
27631520	775	785	myometrial	T082	UMLS:C0521387
27631520	775	798	myometrial infiltration	T038	UMLS:C0332448
27631520	830	856	aggressive clinical course	T033	UMLS:C1332223
27631520	878	893	bony metastases	T038	UMLS:C0027627
27631520	920	938	peritoneal disease	T038	UMLS:C0031142
27631520	945	957	chemotherapy	T058	UMLS:C3665472
27631520	974	984	metastases	T038	UMLS:C0027627
27631520	992	996	lung	T017	UMLS:C0024109
27631520	1001	1005	skin	T022	UMLS:C1123023
27631520	1033	1036	ESS	T038	UMLS:C0206630
27631520	1058	1064	ZC3H7B	T017	UMLS:C1823919
27631520	1067	1071	BCOR	T017	UMLS:C1427193
27631520	1072	1084	gene fusions	T062	UMLS:C0178648
27631520	1088	1107	targeted sequencing	T058	UMLS:C1294197
27631520	1112	1146	fluorescence in situ hybridization	T062	UMLS:C0162789
27631520	1204	1207	ESS	T038	UMLS:C0206630
27631520	1213	1219	ZC3H7B	T017	UMLS:C1823919
27631520	1222	1226	BCOR	T017	UMLS:C1427193
27631520	1227	1233	fusion	T062	UMLS:C0178648
27631520	1262	1276	high-grade ESS	T038	UMLS:C2239246
27631520	1300	1319	morphologic overlap	T033	UMLS:C1513488
27631520	1325	1346	myxoid leiomyosarcoma	T038	UMLS:C0205816